Company Description
Houlihan Lokey, Inc., an investment banking company, provides merger and acquisition (M&A), capital market, financial restructurings and liability management, and financial and valuation advisory services worldwide.
The company operates in three segments: Corporate Finance (CF), Financial Restructuring (FR), and Financial and Valuation Advisory (FVA).
The CF segment offers general financial advisory services; and advises public and private institutions, including financial sponsors on buy-side and sell-side M&A transactions, debt and equity financings in both the private and public markets, and other corporate finance transactions.
The FR segment advises debtors, creditors, and other parties-in-interest related to recapitalization/deleveraging transactions.
This segment also provides a range of advisory services, such as structuring, negotiation, and confirmation of plans of reorganization; structuring and analysis of exchange offers; liability management transactions; corporate viability assessment; dispute resolution and expert testimony; and procuring debtor-in-possession financing.
The FVA segment provides valuation services to companies; debt and equity interests comprising illiquid investments; and other assets and liabilities.
This segment also offers fairness opinions in connection with M&A and other transactions; solvency opinions in connection with corporate spin-offs and dividend recapitalizations; and other types of financial opinions, as well as provides dispute resolution services.
It serves corporations, financial sponsors, and government agencies. Houlihan Lokey, Inc. was incorporated in 1972 and is headquartered in Los Angeles, California.
Country | United States |
Founded | 1972 |
IPO Date | Aug 13, 2015 |
Industry | Capital Markets |
Sector | Financials |
Employees | 2,702 |
CEO | Scott Adelson |
Contact Details
Address: 10250 Constellation Boulevard, 5th Floor Los Angeles, California 90067 United States | |
Phone | 310 553 8871 |
Website | hl.com |
Stock Details
Ticker Symbol | HLI |
Exchange | NYSE |
Stock Type | Common Stock |
Share Class | Class A Shares |
Fiscal Year | April - March |
Reporting Currency | USD |
CIK Code | 0001302215 |
CUSIP Number | 441593100 |
ISIN Number | US4415931009 |
Employer ID | 95-2770395 |
SIC Code | 6282 |
Key Executives
Name | Position |
---|---|
Scott Joseph Adelson | Chief Executive Officer and Director |
Irwin N. Gold J.D. | Co-Chairman and Chairman of the Board |
Scott Lee Beiser | Co-Chairman and Director |
J. Lindsey Alley | MD and Chief Financial Officer |
Christopher M. Crain J.D. | MD, General Counsel and Secretary |
Paul Eric Siegert | Co-Chairman, Global Co-Head of Financial Restructuring and Director |
Craig E. Tessimond | Managing Director |
Nana Kyei | Managing Director of Technology Group |
Jacques Cornet | Investor Relations Professional |
Charles A. Yamarone | Chief Corporate Governance and Compliance Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Aug 5, 2025 | 10-Q | Quarterly Report |
Jul 30, 2025 | 8-K | Current Report |
Jul 25, 2025 | ARS | Filing |
Jul 25, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Jul 25, 2025 | DEF 14A | Other definitive proxy statements |
Jul 14, 2025 | 144 | Filing |
Jun 30, 2025 | 144 | Filing |
Jun 13, 2025 | 144 | Filing |
Jun 2, 2025 | 144 | Filing |
May 19, 2025 | 144 | Filing |